Global Tuberculosis Diagnostics Market USD 2.8 Billion by 2020

Global Tuberculosis Diagnostics Market USD 2.8 Billion by 2020

Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis. The bacteria usually attack the lungs but TB bacteria can attack any part of the body such as the kidney, spine and brain. Not everyone infected with TB bacteria becomes sick. As a result, two TB- related conditions exist: latent TB infection(LTBI) and TB disease. TB is one of the leading causes of death worldwide.

According to a market research report Tuberculosis Diagnostics Market 2016-2020, published by iHealthcareAnalyst, Inc., the global tuberculosis diagnostics market is estimated to reach USD 2.8 Billion in 2020, expanding at a CAGR of 5.9% from 2016 to 2020.

Visit the Tuberculosis Diagnostics Market 2016-2020 report at https://www.ihealthcareanalyst.com/report/tuberculosis-diagnostics-market/

The global tuberculosis diagnostics market segmentation is based on test type (smear microscopy, culture based tests, nucleic acid testing, Mantoux test, radiography, drug susceptibility testing, serological tests, IGRA, etc.). The global tuberculosis diagnostics market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020).

The global tuberculosis diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Test Type
1.1 Smear Microscopy
1.2 Culture Based Tests
1.3 Nucleic Acid Testing
1.4 Mantoux Test (TuberculinSkin Test)
1.5 Radiography (Chest X-Ray)
1.6 Drug Susceptibility Testing (DST)
1.7 Other Tests (Serological Tests, IGRA)

2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World

3. Company Profiles
3.1 Abbott Laboratories
3.2 Akonni Biosystems, Inc.
3.3 Alere, Inc.
3.4 Beckton, Dickinson and Company
3.5 bioMerieux SA
3.6 Cepheid
3.7 Epistem Holdings Plc
3.8 Hain Lifescience GmbH
3.9 Hoffmann-La Roche Ltd.
3.10 Hologic, Inc.
3.11 Sanofi
3.12 Thermo Fisher Scientific, Inc.
3.13 Qiagen 

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: http://www.ihealthcareanalyst.com


 

2016-10-17T04:29:35+00:00 Categories: Press Releases|
Translate »